EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
   3.4.17.18 | Abortion, Spontaneous |
28846048 |
Communicated Sense-making After Miscarriage: A Dyadic Analysis of Spousal Communicated Perspective-Taking, Well-being, and Parenting Role Salience. |
unassigned |
0 |
| 3.4.17.18 | Abscess |
12761313 |
Percutaneous abscess drainage: use of related radiology services and associated economic impact on a radiology practice. |
causal interaction
therapeutic application
unassigned |
2
1
0 |
| 3.4.17.18 | Abscess |
26522771 |
Pediatric renal abscesses: A contemporary series. |
diagnostic usage
unassigned |
1
0 |
| 3.4.17.18 | Abscess |
31140853 |
Oxytetracycline concentrations in interstitial fluid from tissue chambers inoculated with Corynebacterium pseudotuberculosis after intramuscular or intrachamber administration in sheep. |
diagnostic usage
ongoing research
therapeutic application
unassigned |
1
3
1
0 |
| 3.4.17.18 | Abscess |
31981920 |
Lateral cervical abscesses: NSQIP-P perspective on length of stay, readmission, and reoperation. |
therapeutic application
unassigned |
1
0 |
| 3.4.17.18 | Acidosis |
16740614 |
Involvement of adenosine in depression of synaptic transmission during hypercapnia in isolated spinal cord of neonatal rats. |
therapeutic application
unassigned |
2
0 |
| 3.4.17.18 | Acne Vulgaris |
27441661 |
Ethosomes Loaded with Cryptotanshinone for Acne Treatment through Topical Gel Formulation. |
therapeutic application
unassigned |
4
0 |
| 3.4.17.18 | Acne Vulgaris |
32476076 |
Formulation and Characterization of a 3D-Printed Cryptotanshinone-Loaded Niosomal Hydrogel for Topical Therapy of Acne. |
ongoing research
therapeutic application
unassigned |
1
4
0 |
| 3.4.17.18 | Acne Vulgaris |
34539397 |
Integrated Proteomics and Metabolomics Link Acne to the Action Mechanisms of Cryptotanshinone Intervention. |
causal interaction
therapeutic application
unassigned |
1
4
0 |
| 3.4.17.18 | Adenocarcinoma |
9391553 |
A phase II study of topotecan administered five times daily in patients with advanced gastric cancer. |
causal interaction
therapeutic application
unassigned |
1
2
0 |
